Aldeyra Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 9.28 M | $53.34 M | 0.00% | 15.59% |
KNOLL CAPITAL MANAGEMENT, LLC | 05/15/2025 | 5.48 M | $31.48 M | 0.00% | 9.20% |
BLACKROCK, INC. | 05/02/2025 | 3.74 M | $21.48 M | -1.43% | 6.24% |
VANGUARD GROUP INC | 05/09/2025 | 3.72 M | $21.38 M | -1.03% | 6.21% |
ARDSLEY ADVISORY PARTNERS LP | 05/15/2025 | 1.75 M | $9.89 M | 52.17% | 2.92% |
KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2025 | 1.23 M | $7.09 M | -16.01% | 2.06% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 1.14 M | $6.54 M | 1.63% | 1.90% |
STATE STREET CORP | 05/15/2025 | 1.02 M | $5.87 M | -1.16% | 1.71% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 05/15/2025 | 779.00 K | $4.48 M | 100.00% | 1.30% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 669.85 K | $3.85 M | -8.96% | 1.12% |
MORGAN STANLEY | 05/15/2025 | 555.06 K | $3.19 M | -4.25% | 0.93% |
FEDERATED HERMES, INC. | 05/08/2025 | 551.09 K | $3.17 M | 0.13% | 0.92% |
INVESCO LTD. | 05/12/2025 | 501.14 K | $2.88 M | 1,575.71% | 0.84% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 476.00 K | $2.74 M | 64.14% | 0.79% |
RAYMOND JAMES FINANCIAL INC | 05/13/2025 | 451.92 K | $2.60 M | -37.85% | 0.75% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 408.54 K | $2.35 M | 33.40% | 0.68% |
ARDSLEY ADVISORY PARTNERS LP | 05/15/2025 | 400.00 K | $2.30 M | -33.33% | 0.67% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 392.56 K | $2.26 M | 456.32% | 0.66% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 392.53 K | $2.26 M | -0.29% | 0.66% |
NORTHERN TRUST CORP | 05/13/2025 | 389.58 K | $2.24 M | -3.93% | 0.65% |
05/12/2025 | 348.52 K | $10.03 M | 100.00% | 0.58% | |
DEUTSCHE BANK AG\ | 05/09/2025 | 314.42 K | $1.81 M | -1.52% | 0.53% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 300.80 K | $1.73 M | -24.72% | 0.50% |
PALO ALTO INVESTORS LP | 05/15/2025 | 225.47 K | $1.30 M | 0.00% | 0.38% |
WOODSTOCK CORP | 04/09/2025 | 223.09 K | $1.28 M | 14.45% | 0.37% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 211.58 K | $1.22 M | -67.35% | 0.36% |
CAPTION MANAGEMENT, LLC | 05/15/2025 | 181.11 K | $1.04 M | -54.32% | 0.30% |
JANE STREET GROUP, LLC | 05/19/2025 | 178.11 K | $1.02 M | 100.00% | 0.30% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 164.41 K | $945.36 K | -19.47% | 0.27% |
TREXQUANT INVESTMENT LP | 05/14/2025 | 158.12 K | $909.17 K | 38.12% | 0.26% |
D. E. SHAW & CO., INC. | 05/15/2025 | 151.64 K | $871.94 K | -19.59% | 0.25% |
05/06/2025 | 151.28 K | $869.86 K | 0.00% | 0.25% | |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 137.99 K | $793.41 K | 0.92% | 0.23% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 135.16 K | $777.14 K | -16.53% | 0.23% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 124.37 K | $715.10 K | -48.25% | 0.21% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 117.48 K | $675.48 K | 100.00% | 0.20% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 116.60 K | $670.45 K | -30.22% | 0.19% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 111.60 K | $641.70 K | 106.28% | 0.19% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 110.93 K | $637.85 K | -5.01% | 0.19% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 95.96 K | $551.00 K | 7,402.74% | 0.16% |
UBS GROUP AG | 05/13/2025 | 94.47 K | $543.20 K | 0.21% | 0.16% |
CITADEL ADVISORS LLC | 05/15/2025 | 79.50 K | $457.13 K | -6.03% | 0.13% |
STRS OHIO | 05/28/2025 | 76.50 K | $439.88 K | -21.86% | 0.13% |
RHUMBLINE ADVISERS | 05/29/2025 | 75.48 K | $433.98 K | -3.47% | 0.13% |
HENNION & WALSH ASSET MANAGEMENT, INC. | 04/10/2025 | 69.44 K | $399.29 K | -18.73% | 0.12% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 65.31 K | $375.52 K | -28.82% | 0.11% |
ALLIANCEBERNSTEIN L.P. | 05/15/2025 | 58.65 K | $337.24 K | 0.00% | 0.10% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 55.33 K | $318.13 K | -57.90% | 0.09% |
PFG INVESTMENTS, LLC | 04/22/2025 | 51.75 K | $297.56 K | -85.12% | 0.09% |
BARCLAYS PLC | 05/15/2025 | 50.96 K | $293.00 K | -32.36% | 0.09% |
Aldeyra Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 152 institutional investors and hedge funds held shares of Aldeyra Therapeutics, Inc.. The most heavily invested institutionals were:
WOLFF WIESE MAGANA LLC: 0
Parallel Advisors, LLC: 0
PERCEPTIVE ADVISORS LLC: 9.28 M
Knoll Capital Management, LLC: 5.48 M
BlackRock, Inc.: 3.74 M
VANGUARD GROUP INC: 3.72 M
63.26% of Aldeyra Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.42 M shares in the last 24 months. This purchase volume represents approximately $234.58 M in transactions.